Intellectual property sharing agreements in gene technology: Implications for research and commercialisation

International Journal of Intellectual Property Management

Volumn 4, Issue 3, 2011, Pages 179-190

  Smyth, Stuart J ^a   Gray, Richard ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Biotechnology; Commercialisation; Cross licensing; Genetic traits; Innovation; Oligopoly

Indexed keywords

EID: 84865355493     PISSN: 14789647     EISSN: 14789655     Source Type: Journal    
DOI: 10.1504/IJIPM.2011.041082     Document Type: Article

References (14)

1. Buchanan, J.M. and Yoon, Y.J. (2000) 'Symmetric tragedies: commons and anticommons', The Journal of Law and Economics, Vol. 43, No. 1, pp.1-14.
2. Ex parte Hibberd (1985) 227 U.S.P.Q. 443, Board of Patent Appeals and Interferences.
3. Falcon, W.P. and Fowler, C. (2002) 'Carving up the commons-emergence of a new international regime for germplasm development and transfer', Food Policy, Vol. 27, pp.197-222.
4. Gold, R. (2001) Patenting Life Forms: An International Comparison, Report submitted to the Canadian Biotechnology Advisory Committee, available at http://www.cbaccccb. ca/epic/internet/incbac-cccb.nsf/en/ah00399e.html.
5. Graff, G.D., Cullen, S.E., Bradford, K.J., Zilberman, D. and Bennett, A.B. (2003) 'The public-private structure of intellectual property ownership in agricultural biotechnology', Nature Biotechnology, Vol. 21, No. 9, pp.989-995. (Pubitemid 37064723)
6. Heller, M.A. (1998) 'Tragedy of the anticommons: property in the transition from Marx to markets', Harvard Law Review, Vol. 111, No. 3, pp.621-688. (Pubitemid 128019381)
7. Heller, M.A. and Eisenber, R.S. (1998) 'Can patents deter innovation? The anticommons in biomedical research', Science, Vol. 280, No. 5364, pp.698-701. (Pubitemid 28243336)
8. Howard, P.H. (2009) 'Visualizing consolidation in the global seed industry: 1996-2008', Sustainability, Vol. 1, No. 4, pp.1266-1287.
9. Marco, A.C. and Rausser, G.C. (2008) 'The role of patent rights in mergers: consolidation in plant biotechnology', American Journal of Agricultural Economics, Vol. 90, No. 1, pp.133-151. (Pubitemid 351210855)
10. Monsanto Canada Inc. v. Schmeiser (2004) 1 S.C.R. 902.
11. Samuelson, P.A. (1954) 'The pure theory of public expenditure', The Review of Economics and Statistics, Vol. 36, No. 4, pp.387-398.
12. Parisi, F., Schulz, N. and Depoorter, B. (2003) Simultaneous and Sequential Anticommons, Yale Law School John M. Olin Centre for Studies In Law, Economics, and Public Policy Working Paper Series', available at http://www.digitalcommons.law.yale.edu/cgi/viewcontent.cgi?article= 1009&context=lepp-pa pers.
13. Phillips, P.W.B. and Khachatourians, G.G. (2001) The Biotechnology Revolution in Global Agriculture: Invention, Innovation and Investment in the Canola Sector, CABI Publishing, Wallingford, UK.
14. Wright, B.D. (1998) 'Public germplasm development at a crossroads: biotechnology and intellectual property', California Agriculture, Vol. 52, No. 6, pp.8-13.